Nifty 17401.65 (1.37%)
Sensex 58461.29 (1.35%)
Nifty Bank 36508.25 (0.39%)
Nifty IT 36157.85 (2.06%)
Nifty Financial Services 17982.9 (1.26%)
Adani Ports 739.10 (4.40%)
Asian Paints 3180.60 (1.35%)
Axis Bank 676.10 (-0.52%)
B P C L 378.85 (2.74%)
Bajaj Auto 3328.40 (2.43%)
Bajaj Finance 7180.50 (2.01%)
Bajaj Finserv 17758.15 (2.16%)
Bharti Airtel 732.55 (1.43%)
Britannia Inds. 3578.50 (1.22%)
Cipla 921.25 (-0.74%)
Coal India 159.30 (2.41%)
Divis Lab. 4777.30 (0.53%)
Dr Reddys Labs 4662.75 (1.22%)
Eicher Motors 2451.55 (0.54%)
Grasim Inds 1723.85 (2.63%)
H D F C 2807.80 (3.85%)
HCL Technologies 1184.70 (2.42%)
HDFC Bank 1525.75 (1.40%)
HDFC Life Insur. 705.30 (1.65%)
Hero Motocorp 2472.70 (1.00%)
Hind. Unilever 2383.30 (1.64%)
Hindalco Inds. 432.10 (1.69%)
I O C L 120.65 (2.51%)
ICICI Bank 722.40 (-0.73%)
IndusInd Bank 945.55 (1.27%)
Infosys 1748.25 (1.94%)
ITC 225.45 (1.60%)
JSW Steel 646.75 (1.50%)
Kotak Mah. Bank 1964.25 (0.56%)
Larsen & Toubro 1789.20 (0.18%)
M & M 849.55 (1.78%)
Maruti Suzuki 7324.95 (0.71%)
Nestle India 19503.20 (0.54%)
NTPC 128.70 (0.78%)
O N G C 144.00 (1.23%)
Power Grid Corpn 214.50 (3.52%)
Reliance Industr 2482.85 (0.64%)
SBI Life Insuran 1188.05 (1.99%)
Shree Cement 26289.80 (0.76%)
St Bk of India 477.00 (0.36%)
Sun Pharma.Inds. 766.25 (2.80%)
Tata Consumer 773.25 (0.06%)
Tata Motors 479.10 (0.81%)
Tata Steel 1112.40 (2.76%)
TCS 3642.90 (1.82%)
Tech Mahindra 1629.65 (2.65%)
Titan Company 2386.50 (1.11%)
UltraTech Cem. 7323.20 (0.01%)
UPL 698.20 (1.12%)
Wipro 646.80 (1.89%)
INFY

Sun Pharmaceutical Indust..

₹766.25
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Sun Pharma.Inds.

  • Master Rating:
  • Sun Pharm.Industries has an operating revenue of Rs. 36,704.43 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 8% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 40 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sun Pharmaceuticals Industries Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Sun Pharmaceuticals Industries Ltd Synopsis

NSE-Medical-Generic Drugs

Sun Pharma. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 12803.21 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2021. Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050.
  • Market Cap

    INR 183,849.03 Cr

  • Sales

    INR 14,016.76 Cr

  • Shares in Float

    110.37 Cr

  • No of Funds

    824 K

  • Yield

    0.98%

  • Book Value

    7.34

  • U/D Vol Ratio

    1.6

  • LTDebt/Equity

    19%

  • Alpha

    0.03

  • Beta

    0.89

Sun Pharmaceuticals Industries Ltd Ownership
Sun Pharmaceuticals Industries Ltd Management

Sun Pharmaceuticals Industries Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 25040.1624396.2222843.6122322.6121012.47
Fixed Assets Annual Cr 6007.155825.355620.965632.415139.13
Total Non Current Assets Annual Cr 26932.4926469.2126544.3627216.627481.08
Total Current Assets Annual Cr 12066.3411941.1211169.779575.216388.19
Total Assets Annual Cr 38998.8338410.3337714.1336791.8133869.27
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 104.3644101.680595.209493.03887.5775
ROE Annual % 8.5413.163.571.36-0.1
ROCE Annual % 8.1513.4510.126.680.9
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 24.133.6929.3823.388.18

Sun Pharmaceuticals Industries Ltd Technicals

EMA & SMA

CURRENT PRICE

766.25 (2.8)

    • Bullish Moving Averages 5
    • Bearish Moving Averages 11

EMA

  • 20 Day

    780.3

  • 50 Day

    787.25

  • 100 Day

    767.66

  • 200 Day

    710.37

Sun Pharmaceuticals Industries Ltd Resistance and support

749.65 PIVOT

  • First Resistance

    758.95

  • Second Resistance

    772.55

  • Third Resistance

    781.85

  • First Support

    736.05

  • Second Support

    726.75

  • Third Support

    713.15

  • RSI

    43.04

  • MFI

    32.22

  • MACD

    -12.98

  • MACD signal line

    -9.28

Sun Pharmaceuticals Industries Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 5,417,545 246,227,420 45.45%
Week 5,067,917 237,127,836 46.79%
1 Month 3,493,301 164,045,399 46.96%
6 Month 4,268,453 172,915,051 40.51%

Sun Pharmaceuticals Industries Ltd Price change analysis

-49.15

Over 1 month

Low High
740.1 822

-23.7

Over 3 month

Low High
740.1 851

88.8

Over 6 months

Low High
652.7 851

221.6

Over Year

Low High
539.45 851

Similar Stocks

News

Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Reg

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details Read More

Sun Pharmaceutical Industries Ltd - 524715 - Intimation Abou

As per Letter attached Read More

Sun Pharmaceutical Industries Ltd - 524715 - Disclosures und

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2 Read More

Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Reg

As per Letter attached Read More

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement u

Intimation of Schedule of Analyst / Institutional Investor Meeting Read More

Blogs

FAQs